Market Highlights:

The global protein sequencing market Size held a market value of USD 892.5 million in 2017 and is projected to register a CAGR of 3.6% over the forecast period. The surging focus on target-based drug development by the biotechnological companies is likely to contribute to the market growth. Protein sequencing can be defined as the methods which are used to determine the amino acid sequence of peptides or proteins for analysing the sequence. It is a popular novo sequencing method which enables the researchers to obtain the information regarding protein confirmation. Target-based drug discovery is one of its prominent applications. Experimental methods and computational methods like Mass Spectrometry and Edman degradation are used for protein sequencing.

Market Potential and Pitfalls:

The global protein sequencing market is witnessing a sturdy growth rate owing to the surging focus on target-based drug development by the pharmaceutical and biotechnological companies, advancements made in the clinical mass spectrometry and analytical techniques, and rising financial support by the private and public sector for proteomic research. For instance, the National Cancer Institute Office of Cancer Clinical Proteomics Research offers funding opportunities for proteomics research.

Recent advancements made in the analytical methods and novo peptide-sequencing methods with the application of neural networks have created new opportunities for the market to expand. For instance, technological advancements in mass spectrometer are likely to favor its growth. The surging funding on proteomics research in several developed and developing economies is likely to contribute to market growth. Moreover, the increased demand for protein biomarkers in the process of drug development is fueling its demand across the globe. Moreover, technological advancements in identifying isobaric residues in protein sequences is anticipated to unlock vast prospect in the market globally.

On the contrary, the high cost of the instruments like mass spectrometers and the infrastructure are likely to hinder the market growth across the globe. On a brighter note, the rising application of protein sequencing service techniques in order to identify novel peptides in human antigens and antibodies are likely to boost the market in the long run.

Key Players:

Some of the prominent players in the global protein sequencing market are Proteome Factory, Bioinformatics Solutions, Charles River Laboratories, Agilent Technologies, Inc., Rapid Novor Inc., Selvita, SGS, Shimadzu Corporation, Thermo Fisher Scientific Inc., and Waters Corporation.

Regional Analysis:

Geographically, the protein sequencing market spans across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.

Considering the global scenario, the American region is considered to dominate the global market due to the surging application of protein sequencing in proteomic research, high availability of research funding, and the development of protein sequencing in this region.

The European region is estimated to occupy the second spot in the global market. The growth has been ascribed to the increased availability of funding along with infrastructure for research and rising proteomics research. For instance, a leading proteomics company in Switzerland, Biognosys, raised funds for making proteomics a broader segment in life science research in July 2017.

The Asia Pacific region is likely to expand at the fastest growth rate due to the increased funding for the healthcare sector, rising number of pharmaceutical companies, and growing expenditure on R&D activities in this region.

Market Segmentation:

The global protein sequencing market has been segmented on the basis of technology, products and services, and application.

By mode of products and services, the global protein sequencing market has been segmented into instruments, reagent and consumables, protein sequencing services, and analysis products/software. Among these, the reagents and consumables segment command for the largest share owing to the ongoing advancements in protein sequencing technologies coupled with the surging number of sequencing procedures.

By mode of technology, the global protein sequencing market has been segmented into Edman degradation and mass spectrometry.

By mode of application, the global protein sequencing market has been segmented into genetic engineering, biotherapeutics, and others. Among these, the biotherapeutics segment is likely to expand at the fastest rate in the coming years. The growth can be ascribed to the benefits of protein sequencing-based approaches for drug development processes, surging demand for targeted drug therapy, advancing technology that offer accurate protein sequencing with the help of mass spectrometry, and growing antibiotic resistance of microbes.

By mode of end-users, the global protein sequencing market has been segmented into academic institutes and research centers, pharmaceutical and biotechnology companies, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com